KF
LEXX icon

Krilogy Financial’s Lexaria Bioscience LEXX Stock Holding History

Krilogy Financial’s Portfolio LEXX Stock Details LEXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.5K Buy
1,610
+300
+23% +$3.25K ﹤0.01% 1062
2026
Q1 		$19.4K Hold
1,310
– – ﹤0.01% 969
2025
Q4 		$16K Hold
1,310
– – ﹤0.01% 919
2025
Q3 		$21.2K Buy
+1,310
New +$19K ﹤0.01% 861

Other funds holding LEXX

ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Krilogy Financial's LEXX Position: Q2 2026 in Review

Krilogy Financial increased its Lexaria Bioscience (LEXX) stake by 23% in Q2 2026, buying an estimated $3.25K and bringing the position to 1,610 shares worth $13.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1062.

Krilogy Financial first reported a position in LEXX in Q3 2025 and has held it in 4 quarters since. The position peaked at $21.2K in Q3 2025. 29 funds tracked by Wall St. Rank hold LEXX as of Q2 2026.

  • Krilogy Financial held 1,610 shares of Lexaria Bioscience worth $13.5K as of Q2 2026.
  • Krilogy Financial bought 300 Lexaria Bioscience shares in Q2 2026, an estimated $3.25K.
  • Lexaria Bioscience made up ﹤0.01% of Krilogy Financial's portfolio in Q2 2026, its #1062 holding.
  • Krilogy Financial first reported a position in Lexaria Bioscience in Q3 2025 and has held it in 4 quarters since.
  • Krilogy Financial's Lexaria Bioscience position peaked at $21.2K in Q3 2025.
  • 29 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q2 2026.

Based on Krilogy Financial's 13F filing for Q2 2026, filed 27 Jul 2026.